PRESS RELEASE
9 April 2025

Advestra advises German Equity Partners IV on Sale of Swiss Healthcare Group Uroviva to Affidea

Advestra advised Ger­man Equity Part­ners IV, a fund man­aged by the inde­pend­ent Ger­man invest­ment com­pany ECM Equity Cap­it­al Man­age­ment, and oth­er sellers on the sale...
Switzerland

Advestra advised German Equity Partners IV, a fund managed by the independent German investment company ECM Equity Capital Management, and other sellers on the sale of Uroviva group, a leading provider of medical services in the field of urology, gynecology and oncology in Switzerland, to Affidea, a leading pan-European provider of specialist healthcare services including cancer care, advanced diagnostic imaging and community-based polyclinics, backed by the listed investment holding company Groupe Bruxelles Lambert.

Advestra acted as Swiss legal counsel to the sellers in this transaction. The team included Beda Kaufmann, Alexander von Jeinsen, Göktuğ Gürbüz, Angelika Kremer, Anna Capaul, Silvan Biedermann, Annina Hammer, Lina Eisenhut and Jill Iten (all Corporate | M&A and/or Finance) and Céline Martin (Tax).

Contributor

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More